LC
NVS icon

Lilley & Co’s Novartis NVS Stock Holding History

Lilley & Co’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$387K Sell
4,763
-1,387
-23% -$109K 0.17% 78
2014
Q1 		$469K Sell
6,150
-3,942
-39% -$287K 0.21% 72
2013
Q4 		$727K Sell
10,092
-356
-3% -$24.7K 0.34% 62
2013
Q3 		$719K Buy
10,448
+144
+1% +$9.53K 0.38% 59
2013
Q2 		$653K Buy
+10,304
New +$670K 0.35% 61

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Lilley & Co's NVS Position: Q2 2014 in Review

Lilley & Co reduced its Novartis (NVS) stake by 23% in Q2 2014, selling an estimated $109K and leaving 4,763 shares worth $387K. The position accounts for 0.17% of the portfolio, ranked #78.

Lilley & Co first reported a position in NVS in Q2 2013 and has held it in 5 quarters since. The position peaked at $727K in Q4 2013. 847 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

  • Lilley & Co held 4,763 shares of Novartis worth $387K as of Q2 2014.
  • Lilley & Co sold 1,387 Novartis shares in Q2 2014, an estimated $109K.
  • Novartis made up 0.17% of Lilley & Co's portfolio in Q2 2014, its #78 holding.
  • Lilley & Co first reported a position in Novartis in Q2 2013 and has held it in 5 quarters since.
  • Lilley & Co's Novartis position peaked at $727K in Q4 2013.
  • 847 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on Lilley & Co's 13F filing for Q2 2014, filed 14 Jul 2014.